Announcement: Gastroenterology and Hepatology program ranked in top 25 globally

In a subject-based global ranking developed by US News’ Best Global Universities, Schulich Medicine & Dentistry’s Gastroenterology and Hepatology program ranked 22nd worldwide.

The School’s program also scored second highest among Canadian institutions.

The Best Global Universities rankings compare post-secondary institutions from more than 85 countries based on various criteria, including program-based and regional lists. The Gastroenterology and Hepatology programs were ranked according to various measures of academic research performance, including the number and impact of publications and citations, international collaboration and conference presence. 

Dr. Karim Qumosani, Gastroenterology and Hepatology Program Director, says fostering a strong research presence starts with the trainees. 

“Over the course of trainees’ two years of training, four research blocks have been built into their rotation schedule,” he said. “Residents also have the opportunity to utilize their elective block as an additional block of research. The collegiality of our program, along with patient volume, diversity of patient presentation types and procedural exposure is what makes our program desired by trainees interested in this area of research.”

From the indicators used to determine the ranking, the School’s program was first in international collaboration, and third in terms of impact through conference presence.

“Not only is this an outstanding accomplishment for the Division of Gastroenterology,it is also an accomplishment for the Department of Medicine and the School. This accomplishment reflects the hard work, collegiality, and commitment our division has to residency education, and more specifically to research,” said Dr. Qumosani, pointing to a number of ongoing high-profile research initiatives. 

The program is involved in research into predicting graft success in organ donation, examining drug disposition in non-alcoholic fatty liver disease and a clinical trial into dietary intervention for patients with celiac disease and diabetes, among others.